Test for coronavirus (COVID 19) in the network of diagnostic laboratories "NeoLab"

• Blood sampling with sterile, disposable test systems.

The enzyme-linked immunosorbent assay (ELISA) is a laboratory diagnostic method that detects antibodies to a viral disease. The ELISA method has a high reliability of the result and recognizes the presence of an infectious agent at an early stage. The high manufacturability of the analysis excludes errors in the issuance of results. The analysis can determine the presence of immunity to the disease.
IgG antibodies indicate a chronic stage of the disease and the presence of immunity in the body. Indicate the immune defense to the disease, if it has been transferred.

• Blood sampling with sterile, disposable test systems.

The presence of M class antibodies in the blood indicates that the patient was recently infected with the SARS CoV-22019 virus. IgM immunoglobulins can be detected no earlier than 7-15 days after contact with the source of the virus (no earlier than 5 days after the onset of symptoms). The result of such a test is not a basis for diagnosing a disease for accuracy, it is recommended to pass a PCR test.

• Blood sampling with sterile, disposable test systems.

The presence of class A antibodies in the blood allows you to determine that a person is infected in the very first days of the disease. It is better to take such an analysis 4-7 days after the first symptoms appear. IgA antibody level rises up to 14 days after the onset of the disease.

Coronavirus (COVID 19), antigen determination

• Blood sampling with sterile, disposable test systems.

The COVID-19 (Ag) coronavirus antigen test is a new research method for the early diagnosis of coronavirus infection.
The COVID-19 virus antigen test contains a high diagnostic specificity (99.8%) and a sensitivity (91.4%) of the test.
A rapid antigen test is used as a preliminary screening examination in the early days of the disease, when the concentration of the virus in the nasopharynx is maximum.
Analysis result within 30 minutes. Testing is carried out directly with the patient.
Biomaterial for analysis - a swab from the nasal mucosa (nasopharyngeal swab).

• Biomaterial collection with sterile, disposable systems.

Determination of the presence of coronavirus infection by the PCR method (polymerase chain reaction). The PCR method is the standard of laboratory diagnostics. Research material - a swab from the mouth and nose. The analysis period is 48 hours.